Pasar al contenido principal

PAPEL DEL FACTOR DE TRANSCRIPCION TCFL5/CHA EN EL DESARROLLO NORMAL Y PATOLOGICO DE LOS LINFOCITOS T Y B.

SAF2016-75988-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genome sequence of Trypanosoma cruzi strain Bug2148

  • Callejas-Hernández, Francisco
  • Gironès, Núria
  • Fresno, Manuel
Trypanosoma cruzi belongs to the group of mitochondrion-containing eukaryotes and has a highly plastic genome, unusual gene organization, and complex mechanisms for gene expression (polycistronic transcription). We report here the genome sequence of strain Bug2148, the first genomic sequence belonging to cluster TcV, which has been related to vertical transmission., Consejo de Ciência, Tecnología e Innovación de Hidalgo (CITNOVA, Mexico); by Ministerio de Economía y Competitividad grant SAF2015-63868-R (MINECO/FEDER) to N.G. and SAF2016-75988-R (MINECO/FEDER) to M.F.; by Red de Investigación Colaborativa en Enfermedades Tropicales (RICET grant RD12/0018/0004) to M.F.; by the European Union (grant HEALTH-FE-2008-22303, ChagasEpiNet) to M.F.; and by the Comunidad de Madrid (grant S-2010/BMD-2332) and institutional grants from Fundación Ramón Areces., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

DUSP10 is a regulator of YAP1 activity promoting cell proliferation and colorectal cancer progression

  • Jiménez-Martínez, Marta
  • Ostalé, Cristina M.
  • Van der Burg, Lennart R.
  • Galán-Martínez, Javier
  • Hardwick, James C. H.
  • López-Pérez, Ricardo
  • Hawinkels, Lukas J. A. C.
  • Stamatakis, Konstantinos
  • Fresno, Manuel
Cell contact inhibition (CCI) is deregulated in cancer. Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide. We found that dual-specificity phosphatase 10 (DUSP10) is involved in CRC. DUSP10 overexpression increased the growth of CRC cell lines and mouse xenografts, while the opposite phenotype was observed by DUSP10 silencing. High cell density (HD) induced DUSP10 expression in CRC cell lines, particularly within the nucleus. Yes-associated protein 1 (YAP1) is activated by dephosphorylation, controlling organ growth and CCI, both processes being deregulated in CRC. Expression levels and localization of DUSP10 matched with YAP1 levels in CRC cell lines. DUSP10 and YAP1 co-immunoprecipitated and their interaction was dependent on YAP1 Ser397. The existence of DUSP10 and YAP1 pathway in vivo was confirmed by using a transgenic Drosophila model. Finally, in CRC patients’ samples, high levels of nuclear DUSP10 correlated with nuclear YAP1 in epithelial tumor tissue. Strong nuclear DUSP10 staining also correlated with high tumor stage and poor survival. Overall, these findings describe a DUSP10–YAP1 molecular link in CRC cell lines promoting cell growth in HD. We present evidence suggesting a pro-tumorigenic role of nuclear DUSP10 expression in CRC patients., This research was funded by grants from “Ministerio de Ciencia e Innovación” (SAF2013-42850-R and SAF2016-75988-R) “Comunidad de Madrid (S2017/BMD-3671. INFLAMUNE-CM), Fondo de Investigaciones Sanitarias” (BIOIMID) to M.F. K.S. was the recipient of a Spanish Association Against Cancer oncology investigator grant (AECC AIO).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The dual-specificity phosphatase 10 (DUSP10): Its role in cancer, inflammation, and immunity

  • Jiménez-Martínez, Marta
  • Stamatakis, Konstantinos
  • Fresno, Manuel
Cancer is one of the most diagnosed diseases in developed countries. Inflammation is a common response to different stress situations including cancer and infection. In those processes, the family of mitogen-activated protein kinases (MAPKs) has an important role regulating cytokine secretion, proliferation, survival, and apoptosis, among others. MAPKs regulate a large number of extracellular signals upon a variety of physiological as well as pathological conditions. MAPKs activation is tightly regulated by phosphorylation/dephosphorylation events. In this regard, the dual-specificity phosphatase 10 (DUSP10) has been described as a MAPK phosphatase that negatively regulates p38 MAPK and c-Jun N-terminal kinase (JNK) in several cellular types and tissues. Several studies have proposed that extracellular signal-regulated kinase (ERK) can be also modulated by DUSP10. This suggests a complex role of DUSP10 on MAPKs regulation and, in consequence, its impact in a wide variety of responses involved in both cancer and inflammation. Here, we review DUSP10 function in cancerous and immune cells and studies in both mouse models and patients that establish a clear role of DUSP10 in different processes such as inflammation, immunity, and cancer., Ministerio de Ciencia e Innovación (SAF2013-42850-R and SAF2016-75988-R) Comunidad de Madrid (S2017/BMD-3671. INFLAMUNE-CM), Fondo de Investigaciones Sanitarias (BIOIMID) to M.F. K.S. was recipient of a Spanish Association Against Cancer oncology investigator grant (AECC AIO), We acknowledge support by the CSIC Open Access Publication Initiative through its Unit of Information Resources for Research (URICI)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Epitopes for Multivalent Vaccines Against Listeria, Mycobacterium and Streptococcus spp: A Novel Role for Glyceraldehyde-3-Phosphate Dehydrogenase

  • Álvarez-Domínguez, Carmen
  • Salcines-Cuevas, David
  • Teran-Navarro, Héctor
  • Calderon-Gonzalez, Ricardo
  • Tobes, Raquel
  • García, Isabel
  • Grijalvo, Santiago
  • Paradela, Alberto
  • Seoane, Asunción
  • Sangari, Félix J.
  • Fresno, Manuel
  • Calvo-Montes, Jorge
  • Pérez Del Molino Bernal, I. Concepción
  • Yañez-Diaz, Sonsoles
© 2020 Alvarez-Dominguez, Salcines-Cuevas, Teran-Navarro, Calderon-Gonzalez, Tobes, Garcia, Grijalvo, Paradela, Seoane, Sangari, Fresno, Calvo-Montes, Pérez Del Molino Bernal and Yañez-Diaz., The glycolytic enzyme and bacterial virulence factor of Listeria monocytogenes, the glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Lmo2459), ADP-ribosylated the small GTPase, Rab5a, and blocked phagosome maturation. This inhibitory activity localized within the NAD binding domain of GAPDH at the N-terminal 1–22 peptides, also conferred listeriosis protection when used in dendritic cell-based vaccines. In this study, we explore GAPDH of Listeria, Mycobacterium, and Streptococcus spp. taxonomic groups to search for epitopes that confer broad protection against pathogenic strains of these bacteria. GAPDH multivalent epitopes are selected if they induce inhibitory actions and wide-ranging immune responses. Proteomic isolation of GAPDH from dendritic cells infected with Listeria, Mycobacterium, or Streptococcus confirmed similar enzymatic, Rab5a inhibitory and immune stimulation abilities. We identified by bioinformatics and functional analyses GAPDH N-terminal 1–22 peptides from Listeria, Mycobacterium, and Streptococcus that shared 95% sequence homology, enzymatic activity, and B and T cell immune domains. Sera obtained from patients or mice infected with hypervirulent pathogenic Listeria, Mycobacterium, or Streptococcus presented high levels of anti-GAPDH 1–22 antibodies and Th2 cytokines. Monocyte derived dendritic cells from healthy donors loaded with GAPDH 1–22 peptides from Listeria, Mycobacterium, or Streptococcus showed activation patterns that correspond to cross-immunity abilities. In summary, GAPDH 1–22 peptides appeared as putative candidates to include in multivalent dendritic based vaccine platforms for Listeria, Mycobacterium, or Streptococcus., This research was funded by the CICYT program of the Ministry of Science and Innovation, grant number SAF2012-34203, the Instituto de Salud Carlos III (ISCIII) grant numbers, DTS18-00022 and PI19-01580 to CA-D, the intramural CIBER-BNN grant number, CIB16-NM009 to IG and CA-D, to the Bio-health Research Program of Cantabria Government, grant number INNVAL19/26 to SY-D, CM, and CA-D; SAF2016-75988-R “Comunidad de Madrid (S2017/BMD-3671. INFLAMUNECM) and Fondo de Investigaciones Sanitarias” (BIOIMID) to MF and a Predoctoral contract to DS-C by Bio-health research program of Cantabria government. This study was co-funded in part with European FEDER funds, "A new way of making Europe" as well as funds from the COST European action ENOVA.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

ACE2 Serum Levels as Predictor of Infectability and Outcome in COVID-19

  • Maza, María del Carmen
  • Úbeda, María
  • Delgado, Pilar
  • Horndler, Lydia
  • Llamas, Miguel Ángel
  • Santen, Hisse M. van
  • Alarcón, Balbino
  • Abia, David
  • García-Bermejo, Laura
  • Serrano-Villar, Sergio
  • Bastolla, Ugo
  • Fresno, Manuel
Background: COVID‐19 can generate a broad spectrum of severity and symptoms. Many studies analysed the determinants of severity but not among some types of symptoms. More importantly, very few studies analysed patients highly exposed to the virus that nonetheless remain uninfected. Methods: We analysed serum levels of ACE2, Angiotensin II and anti-Spike antibodies in 2 different cohorts at high risk of viral exposure, highly exposed but uninfected subjects, either high risk health care workers or persons cohabiting with infected close relatives and seropositive patients with symptoms. We tested the ability of the sera of these subjects to neutralize lentivirus pseudotyped with the Spike-protein. Results: We found that the serum levels of ACE2 are significantly higher in highly exposed but uninfected subjects. Moreover, sera from this seronegative persons can neutralize SARS-CoV-2 infection in cellular assays more strongly that sera from non-exposed negative controls eventhough they do not have anti-CoV-2 IgG antibodies suggesting that high levels of ACE2 in serum may somewhat protect against an active infection without generating a conventional antibody response. Finally, we show that among patients with symptoms, ACE2 levels were significantly higher in infected patients who developed cutaneous as compared with respiratory symptoms and ACE2 was also higher in those with milder symptoms. Conclusions: These findings suggest that soluble ACE2 could be used as a potential biomarker to predict SARS-CoV-2 infection risk and to discriminate COVID-19 disease subtypes., This research was funded by grants from “Ministerio de Ciencia e Innovación” (SAF2013-42850-R, SAF2016-75988-R and PID-2019104760RB-100; FEDER), “Comunidad de Madrid (S2017/BMD-3671. INFLAMUNE-CM; FEDER) to MF, Consejo Superior de Investigaciones Científica, CSIC (CSIC-COV19-108, SGL210235) to MF and UB, CRUE-Supera COVID, the European Development Regional Fund ‘‘A way to achieve Europe’’ (ERDF), Merck, Sharp & Dohme Investigator Studies Program (code MISP# IIS 60257), and Fondo Supera COVID-19 (2020-001) to SS-V. Institutional grants from “Fundación Ramón Areces” and “Banco de Santander”. This research work was also funded by the European Commission – NextGenerationEU (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI Salud Global)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Quantitative proteomic analysis of macrophages infected with Trypanosoma cruzi reveals different responses dependent on the SLAMF1 receptor and the parasite strain

  • Herreros-Cabello, Alfonso
  • Moral-Salmoral, Javier del
  • Morato-López, Esperanza
  • Marina-Ramírez, Anabel
  • Barrocal, Beatriz
  • Fresno, Manuel
  • Gironès, Núria
This article belongs to the Section Molecular Microbiology., Chagas disease is caused by the intracellular protozoan parasite <i>Trypanosoma cruzi</i>. This disease affects mainly rural areas in Central and South America, where the insect vector is endemic. However, this disease has become a world health problem since migration has spread it to other continents. It is a complex disease with many reservoirs and vectors and high genetic variability. One of the host proteins involved in the pathogenesis is SLAMF1. This immune receptor acts during the infection of macrophages controlling parasite replication and thus affecting survival in mice but in a parasite strain-dependent manner. Therefore, we studied the role of SLAMF1 by quantitative proteomics in a macrophage in vitro infection and the different responses between Y and VFRA strains of <i>Trypanosoma cruzi</i>. We detected different significant up- or downregulated proteins involved in immune regulation processes, which are SLAMF1 and/or strain-dependent. Furthermore, independently of SLAMF1, this parasite induces different responses in macrophages to counteract the infection and kill the parasite, such as type I and II IFN responses, NLRP3 inflammasome activation, IL-18 production, TLR7 and TLR9 activation specifically with the Y strain, and IL-11 signaling specifically with the VFRA strain. These results have opened new research fields to elucidate the concrete role of SLAMF1 and discover new potential therapeutic approaches for Chagas disease., This research was supported by the Ministerio de Economía y competitividad and Fondo Europeo de Desarrollo Regional (SAF2016-75988-R (MINECO/FEDER), SAF2015-63868-R (MINECO/FEDER) to M.F.), Ministerio de Ciencia, Innovación y Universidades-Agencia Estatal de Investigación and Fondo Europeo de Desarrollo Regional (PGC2018-096132-B-I00 and PID2021-123389OB-I00 to N.G.). A.H-C. was a recipient of a FPU contract from the Ministerio de Ciencia, Innovación y Universidades; J.M-S. was a recipient of a Garantía Juvenil predoctoral fellowship (Comunidad de Madrid). Grant PT17/0019, of the PE I + D + i 2013-2016, funded by ISCIII and ERDF., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cyclooxygenase 2 Effector Genes as Potential Inflammation-Related Biomarkers for Colorectal Cancer Circulating Tumor Cells Detection by Liquid Biopsy

  • Stamatakis, Konstantinos
  • Torres-Gérica, Patricia
  • Jiménez-Segovia, Alba
  • Ramos-Muñoz, Edurne
  • Crespo-Toro, Lorena
  • Fuentes, Patricia
  • Toribio, María L.
  • Callejas-Hernández, Francisco
  • Carrato, Alfredo
  • García Bermejo, María Laura
  • Fresno, Manuel
Cyclooxygenase 2 (COX2) has been implicated in cancer development and metastasis. We have identified several COX2-regulated inflammation-related genes in human colorectal cancer cells and shown that some of them play important roles in tumor progression. In this work, we have studied the COX2-regulated genes in the mouse colorectal cancer cell line CT26, to find that many are also regulated by COX2 over-expression. On the other hand, we generated a CT26 cell line expressing Gfp and Luciferase, to study tumor growth and metastasis in immunocompetent Balb/c mice. We then collected solid tissue, and blood samples, from healthy and tumor-bearing mice. Using the Parsortix cell separation system and taking advantage of the fact that the tumor cells expressed Gfp, we were able to identify circulating tumor cells (CTCs) in some of the mice. We compared the mRNA expression levels of Ptgs2 and effector genes in the samples obtained from tumor-bearing or healthy mice, namely, tumor or healthy colon, Ficoll purified buffy coat, and Parsortix-isolated cells to find different patterns between healthy, tumor-bearing mice with or without CTCs. Although for genes like Il15 we did not observe any difference between healthy and tumor-bearing mice in Ficoll or Parsortix samples; others, such as Egr1, Zc3h12a, Klf4, or Nfat5, allowed distinguishing for cancer or CTC presence. Gene expression analysis in Ficoll or Parsortix processed samples, after liquid biopsy, may offer valuable diagnostic and prognostic information and thus should be further studied., This research was funded by grants from “Ministerio de Ciencia e Innovación” (SAF2013-42850-R, SAF2016-75988-R, and PID2019-104760RB-I00), “Comunidad de Madrid (S2017/BMD-3671. INFLAMUNE-CM), Fondo de Investigaciones Sanitarias” (BIOIMID) to MF and Institutional grants from “Fundación Ramón Areces” and “Banco de Santander”. KS was the recipient of a Spanish Association Against Cancer Oncology Investigator grant (AECC AIO).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

NIK Is a Mediator of Inflammation and Intimal Hyperplasia in Endothelial Denudation-Induced Vascular Injury

  • Baeza, Ciro
  • Ribagorda, Marta
  • Maya-López, Carla
  • Fresno, Manuel
  • Sánchez-Díaz, Tania
  • Pintor-Chocano, Aránzazu
  • Sanz, Ana Belén
  • Carrasco, Susana
  • Ortiz, Alberto
  • Sánchez-Niño, Maria D.
Neointimal hyperplasia is the main cause of vascular graft failure in the medium term. NFκB is a key mediator of inflammation that is activated during neointimal hyperplasia following endothelial injury. However, the molecular mechanisms involved in NFκB activation are poorly understood. NFκB may be activated through canonical (transient) and non-canonical (persistent) pathways. NFκB-inducing kinase (NIK, MAP3K14) is the upstream kinase of the non-canonical pathway. We have now explored the impact of NIK deficiency on neointimal hyperplasia following guidewire-induced endothelial cell injury and on local inflammation by comparing NIK activity–deficient alymphoplasia mice (NIKaly/aly) with control wild-type (NIK+/+) mice. Guidewire-induced endothelial cell injury caused neointimal hyperplasia and luminal stenosis and upregulated the local expression of NIK and the NFκB target chemokines monocyte chemoattractant protein-1 (MCP-1/CCL2) and chemokine ligand 5 (RANTES/CCL5). Immunohistochemistry disclosed the infiltration of the media and intima by F4/80 positive macrophages. The intima/media ratio and percentage of stenosis were milder in the NIKaly/aly than in the NIK+/+ mice. Additionally, the gene expression for MCP-1 and RANTES was lower and F4/80+ cell infiltration was milder in the NIKaly/aly than in the NIK+/+ mice. Finally, circulating MCP-1 levels were lower in the NIKaly/aly than in the NIK+/+ mice, reflecting milder systemic inflammation. In conclusion, NIK is a driver of vascular wall inflammation and stenosis following guidewire-induced endothelial cell injury. NIK targeting may be a novel therapeutic approach to limit arterial stenosis following endothelial cell injury., We gratefully acknowledge the Agencia Estatal de Investigación (AEI) MICIN (CNS2022-135937), Sociedad Española de Nefrología, Sociedad Madrileña de Nefrología (SOMANE), FRIAT, Comunidad de Madrid en Biomedicina P2022/BMD-7223, CIFRA_COR-CM. Instituto de Salud Carlos III (ISCIII) FIS/Fondos FEDER (PI22/00050, PI21/00251, ERA-PerMed-JTC2022 (SPAREKID AC22/00027), RICORS program to RICORS2040 (RD21/0005/0001) funded by European Union—NextGenerationEU, Mecanismo para la Recuperación y la Resiliencia (MRR) and SPACKDc PMP21/00109, FEDER funds, COST Action PERMEDIK CA21165, supported by COST (European Cooperation in Science and Technology); PREVENTCKD Consortium. Project ID: 101101220 Program: EU4H DG/Agency: HADEA and from “MICIN” (SAF2016-75988-R and PID2022-137487OB-I00) and “Comunidad de Madrid” (S2017/BMD-3671. INFLAMUNE-CM; FEDER) to MF. MDSN was supported by MICINN Ramon y Cajal program RYC2018-024461-I., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Toll-like receptors ligand immunomodulators for the treatment congenital diaphragmatic hernia

  • Vallejo-Cremades, Mayte
  • Merino, Javier
  • Carmona, Rita
  • Córdoba, Laura
  • Salvador, Beatriz
  • Martínez, Leopoldo
  • Tovar, Juan Antonio
  • Llamas, Miguel Ángel
  • Muñoz-Chápuli, Ramón
  • Fresno, Manuel
Background: Congenital diaphragmatic hernia (CDH) is a rare disease that affects the development of the diaphragm, leading to abnormal lung development. Unfortunately, there is no established therapy for CDH. Retinoic acid pathways are implicated in the ethology of CDH and macrophages are known to play a role in repairing organ damage. Methods: We have analyzed the effect of several Toll like receptor (TLR) ligands in the nitrofen-induced CDH model in pregnant rats widely used to study this disease and in the G2-GATA4;Wt1 CDH genetic mice model. Morphometric and histological studies were carried out. Immune cell infiltration was assayed by immunochemistry and immunofluorescence and retinoic pathway gene expression analyzed in vivo and in vitro in macrophages. Results: We found that administering a single dose of atypical TLR2/4 ligands (CS1 or CS2), 3 days after nitrofen, cured diaphragmatic hernia in 73% of the fetuses and repaired the lesion with complete diaphragm closure being on the other hand nontoxic for the mothers or pups. Moreover, these immunomodulators also improved pulmonary hypoplasia and alveolar maturation and vessel hypertrophy, enhancing pulmonary maturity of fetuses. We also found that CS1 treatment rescued the CDH phenotype in the G2-GATA4;Wt1 CDH genetic mice model. Only 1 out of 11 mutant embryos showed CDH after CS1 administration, whereas CDH prevalence was 70% in untreated mutant embryos. Mechanistically, CS1 stimulated the infiltration of repairing M2 macrophages (CD206 and Arg1) into the damaged diaphragm and reduced T cell infiltration. Additionally, those TLR ligands induced retinol pathway genes, including RBP1, RALDH2, RARα, and RARβ, in the affected lungs and the diaphragm and in macrophages in vitro. Conclusions: Our research has shown that TLR ligand immunomodulators that influence anti-inflammatory macrophage activation can be effective in treating CDH, being nontoxic for the mothers or pups suggesting that those TLR ligands are a promising solution for CDH leading to orphan drug designation for CS1. The immune system of the fetus would be responsible for repairing the damage and closure of the hernia in the diaphragm and enhanced proper lung development after CS1 treatment., This research was funded by grants from “Ministerio de Ciencia e Innovación” (SAF2016-75988-R and PID2022-137487OB-I00) and “Comunidad de Madrid” (S2017/BMD-3671. INFLAMUNE-CM; FEDER) to MF, Asociación de la vida con hernia diafragmatica of Spain to MVC and “Ayuda Real e Ilustre Colegio Oficial de Farmacéuticos de Sevilla”, Fundación MEHUER to BS. The study also received institutional grants from “Fundación Ramón Areces” and “Banco de Santander.”